With Edwards Lifesciences getting a key earnings report out of the way, the uncertainties hanging over EW stock has cleared for the bulls.
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...